Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Galgani

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Vaccines|March 30, 2023
The Impact of Educational Intervention on Willingness to Enroll in a Clinical Trial of a Gonorrhea VaccineMichael Penlington, Uwe Nicolay, Ilaria Galgani
NPJ Vaccines|April 3, 2024
Reverse development of vaccines against antimicrobial-resistant pathogensFabio Bagnoli, Ilaria Galgani, V Kumaran Vadivelu, et al.
Human Vaccines & Immunotherapeutics|January 18, 2020
Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedulesMarco Costantini, Andrea Callegaro, Jiří Beran, et al.
Vaccine|May 4, 2023
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-upJiří Beran, Maria Lattanzi, Marco Costantini, et al.
Vaccine|February 5, 2018
Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistenceJiri Beran, Maria Lattanzi, Fang Xie, et al.
Human Vaccines & Immunotherapeutics|August 19, 2020
Response letter: "Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules"Marco Costantini, Andrea Callegaro, Jiří Beran, et al.
Current Topics in Microbiology and Immunology|February 16, 2017
Vaccines for Staphylococcus aureus and Target PopulationsClarissa Pozzi, Reuben Olaniyi, Lassi Liljeroos, et al.
Expert Review of Vaccines|August 4, 2017
Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedulesIlaria Galgani, Eveline M Bunge, Lisa Hendriks, et al.
Respiratory Research|May 5, 2022
Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind studyIlaria Galgani, Margherita Annaratone, Daniela Casula, et al.
Plos Neglected Tropical Diseases|May 27, 2025
Long-term persistence and boostability of immune responses following different rabies pre-exposure prophylaxis priming schedules of a purified chick embryo cell rabies vaccine administered alone or concomitantly with a Japanese encephalitis vaccineTomas Jelinek, Mirjam Schunk, Emil C Reisinger, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Vaccines|March 30, 2023
The Impact of Educational Intervention on Willingness to Enroll in a Clinical Trial of a Gonorrhea VaccineMichael Penlington, Uwe Nicolay, Ilaria Galgani
NPJ Vaccines|April 3, 2024
Reverse development of vaccines against antimicrobial-resistant pathogensFabio Bagnoli, Ilaria Galgani, V Kumaran Vadivelu, et al.
Human Vaccines & Immunotherapeutics|January 18, 2020
Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedulesMarco Costantini, Andrea Callegaro, Jiří Beran, et al.
Vaccine|May 4, 2023
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-upJiří Beran, Maria Lattanzi, Marco Costantini, et al.
Vaccine|February 5, 2018
Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistenceJiri Beran, Maria Lattanzi, Fang Xie, et al.
Human Vaccines & Immunotherapeutics|August 19, 2020
Response letter: "Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules"Marco Costantini, Andrea Callegaro, Jiří Beran, et al.
Current Topics in Microbiology and Immunology|February 16, 2017
Vaccines for Staphylococcus aureus and Target PopulationsClarissa Pozzi, Reuben Olaniyi, Lassi Liljeroos, et al.
Expert Review of Vaccines|August 4, 2017
Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedulesIlaria Galgani, Eveline M Bunge, Lisa Hendriks, et al.
Respiratory Research|May 5, 2022
Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind studyIlaria Galgani, Margherita Annaratone, Daniela Casula, et al.
Plos Neglected Tropical Diseases|May 27, 2025
Long-term persistence and boostability of immune responses following different rabies pre-exposure prophylaxis priming schedules of a purified chick embryo cell rabies vaccine administered alone or concomitantly with a Japanese encephalitis vaccineTomas Jelinek, Mirjam Schunk, Emil C Reisinger, et al.
Pageof 2